TY - JOUR T1 - Functional network dynamics in progressive multiple sclerosis JF - medRxiv DO - 10.1101/2020.11.26.20238923 SP - 2020.11.26.20238923 AU - Giulia Bommarito AU - Anjali Tarun AU - Younes Farouj AU - Maria Giulia Preti AU - Maria Petracca AU - Amgad Droby AU - Mohamed Mounir El Mendili AU - Matilde Inglese AU - Dimitri Van De Ville Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/30/2020.11.26.20238923.abstract N2 - Functional reorganization at the progressive stage of multiple sclerosis has received limited attention, despite the fact that functional changes are known to occur. Characterizing large-scale network dynamics at rest has the potential to provide new insights into the complexity of such functional alterations. In this case-control study, we explored the dynamic properties of large-scale functional networks during rest in 25 healthy controls and 32 patients with progressive multiple sclerosis, using the innovation-driven co-activation patterns. Thirty-five subjects also underwent a one-year follow-up examination. Partial least squares correlation analysis was applied to explore the relationship between functional dynamics and clinical disability. We observed a reduced dynamic engagement of the anterior default mode network and its coupling with the executive-control network in patients with progressive multiple sclerosis compared to controls, at baseline and follow-up. The global and motor disabilities were related to functional dynamics of subcortical, sensory-motor and posterior default mode network, while the cognitive disability was associated to the altered dynamics of anterior default mode, visual and temporal networks. These findings reveal that the anterior default mode functional recruitment and its interaction with other networks play a major role in the functional reorganization occurring during the progressive stage of multiple sclerosis. Also, the dynamic properties of large-scale functional networks are steady over one year and unveil the intricate relationship between brain function and clinical disability.Competing Interest StatementGiulia Bommarito, Anjali Tarun, Younes Farouj, Maria Giulia Preti, Maria Petracca, Amgad Droby, Mohamed Mounir El Mendili, and Dimitri Van De Ville have nothing to disclose. Matilde Inglese is currently receiving a grant from Teva Neuroscience. Funding StatementG. Bommarito was supported by a research fellowship FISM-Fondazione Italiana Sclerosi Multipla, Cod.: 2017/B/2 and financed or co-financed with the "5 per mille" public funding. A. Tarun and Y. Farouj were supported by the Swiss National Science Foundation under the Project Grant 205321-163376.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol was approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai. Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData supporting the findings of this study will be shared upon request. ER -